M&A Deal Summary

Zoetis Acquires PHARMAQ Holding AS

On November 10, 2015, Zoetis acquired medical products company PHARMAQ Holding AS from Permira for 765M USD

Acquisition Highlights
  • This is Zoetis’ 1st transaction in the Medical Products sector.
  • This is Zoetis’ 2nd largest (disclosed) transaction.
  • This is Zoetis’ 1st transaction in Norway.

M&A Deal Summary

Date 2015-11-10
Target PHARMAQ Holding AS
Sector Medical Products
Buyer(s) Zoetis
Sellers(s) Permira
Deal Type Add-on Acquisition
Deal Value 765M USD

Target

PHARMAQ Holding AS

Overhalla, Norway
PHARMAQ Holding AS is a pharmaceutical company focused on aquaculture. It develops, manufactures and markets vaccines and therapeutic products for the prevention and treatment of diseases in farmed fish.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Zoetis

Parsippany, New Jersey, United States

Category Company
Founded 1952
Sector Life Science
Employees13,800
Revenue 9.3B USD (2024)
DESCRIPTION

Zoetis engages in the discovery, development, manufacture and commercialization of a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock farmers and companion animal owners they support. Zoetis was founded in 1952 and is based in Parsippany, New Jersey.


DEAL STATS #
Overall 4 of 13
Sector: Medical Products M&A 1 of 3
Type: Add-on Acquisition M&A Deals 4 of 12
Country: Norway M&A 1 of 1
Year: 2015 M&A 1 of 1
Size (of disclosed) 2 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-18 Catapult Genetics Pty.

Albion, Australia

Catapult is a global provider of sheep and cattle DNA testing technologies for meat and carcass quality and production efficiency under the GeneSTAR® Quality Grade, Feed Efficiency, the SureTRAK® system, and the SireTRACETM product brands. In addition to co-founders Gerard Davis and Jay Hetzel, shareholders include AgResearch, CSIRO, Kestrel Capital’s Nanyang Innovation Fund, and Meat & Wool New Zealand.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-08 Scandinavian Micro Biodevices ApS

Farum, Denmark

Scandinavian Micro Biodevices ApS is a developer and manufacturer of microfluidic “lab on a chip” diagnostic analyzers and tests for veterinary point-of- care services

Buy $80M

Seller(S) 1

SELLER

Permira

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1985
PE ASSETS 80.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Permira is a mega-sized private equity firm that targets large company investments around the world. Permira invests to support acquisitions, leveraged buyouts, take-privates, turnarounds, and growth buyouts. Areas of interest include healthcare, financial services, chemicals, consumer products and services, industrial products and services, technology, media, and telecom. Permira will consider opportunities in Europe, Asia, and North America. Permira was formed in 1985 and has offices in Menlo Park, Frankfurt, Luxembourg, London, Hong Kong, Madrid, Milan, Paris, Stockholm, Tokyo, Guernsey and New York City.


DEAL STATS #
Overall 54 of 97
Sector: Medical Products M&A 2 of 3
Type: Add-on Acquisition M&A Deals 17 of 30
Country: Norway M&A 1 of 1
Year: 2015 M&A 4 of 4
Size (of disclosed) 30 of 39
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-01 Catawiki

Amsterdam, Netherlands

Catawiki is a platform for collectables, art, design, jewellery, watches, classic cars and more. Every week, its 240+ in-house experts carefully select over 65,000 special objects to put up in auction. Through its protected marketplace, users are assured of an exciting, safe and hassle-free buying experience. Catawiki was founded in 2008 and is based in Amsterdam, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-02 Creganna-Tactx Medical

Galway , Ireland

Creganna-Tactx Medical is a provider of an outsourced design and manufacturing services of minimally invasive delivery and access devices.

Sell $895M